Middle East Africa and Turkey Heart Failure Drug Market Size, Status and Forecast 2019-2025
Summary
In 2018, the Middle East Africa and Turkey Heart Failure Drug market size was 260 million US$ and it is expected to reach 573 million US$ by the end of 2025, with a CAGR of 11.3% during 2019-2025.
This report focuses on the Middle East Africa and Turkey Heart Failure Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Heart Failure Drug development in Middle East Africa and Turkey.
The key players covered in this study
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Market segment by Type, the product can be split into
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Market segment by Ejection Fraction Function, split into
Reduced Ejection Fraction
Preserved Ejection Fraction
Market segment by Countries, this report covers
Turkey
Egypt
South Africa
Saudi Arabia
UAE
- 1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Middle East Africa and Turkey Heart Failure Drug Market Size Growth Rate by Type (2019-2025)
- 1.4.2 Angiotensin-Converting Enzyme (ACE) Inhibitors
- 1.4.3 Angiotensin II Receptor Blockers
- 1.4.4 Angiotensin-Receptor Neprilysin Inhibitors (ARNIs)
- 1.4.5 Aldosterone Antagonists
- 1.4.6 Beta Blockers
- 1.4.7 Diuretics
- 1.5 Market by Ejection Fraction Function
- 1.5.1 Middle East Africa and Turkey Heart Failure Drug Market Share by Ejection Fraction Function (2019-2025)
- 1.5.2 Reduced Ejection Fraction
- 1.5.3 Preserved Ejection Fraction
- 1.6 Study Objectives
- 1.7 Years Considered
- 2 Middle East Africa and Turkey Growth Trends
- 2.1 Middle East Africa and Turkey Heart Failure Drug Market Size
- 2.2 Heart Failure Drug Growth Trends by Country
- 2.2.1 Heart Failure Drug Market Size by Country (2014-2025)
- 2.2.2 Heart Failure Drug Market Share by Country (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
- 3 Market Share by Key Players
- 3.1 Heart Failure Drug Market Size by Manufacturers
- 3.1.1 Middle East Africa and Turkey Heart Failure Drug Revenue by Manufacturers (2018-2019)
- 3.1.2 Middle East Africa and Turkey Heart Failure Drug Revenue Market Share by Manufacturers (2018-2019)
- 3.1.3 Middle East Africa and Turkey Heart Failure Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Heart Failure Drug Key Players Head office and Area Served
- 3.3 Key Players Heart Failure Drug Product/Solution/Service
- 3.4 Establishment Year of Key Heart Failure Drugs Manufacturers
- 3.5 Mergers & Acquisitions, Expansion Plans
- 3.6 Heart Failure Drug Sales Price by Products in 2018
- 4 Breakdown Data by Type and Ejection Fraction Function
- 4.1 Middle East Africa and Turkey Heart Failure Drug Market Size by Type (2014-2019)
- 4.2 Middle East Africa and Turkey Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019)
- 5 Turkey
- 5.1 Turkey Heart Failure Drug Market (2014-2019)
- 5.2 Turkey Heart Failure Drug Market Size by Type
- 5.3 Turkey Heart Failure Drug Market Size by Ejection Fraction Function
- 5.4 Heart Failure Drug Key Players in Turkey
- 6 Egypt
- 6.1 Egypt Heart Failure Drug Market (2014-2019)
- 6.2 Egypt Heart Failure Drug Market Size by Type
- 6.3 Egypt Heart Failure Drug Market Size by Ejection Fraction Function
- 6.4 Heart Failure Drug Key Players in Egypt
- 7 South Africa
- 7.1 South Africa Heart Failure Drug Market (2014-2019)
- 7.2 South Africa Heart Failure Drug Market Size by Type
- 7.3 South Africa Heart Failure Drug Market Size by Ejection Fraction Function
- 7.4 Heart Failure Drug Key Players in South Africa
- 8 Saudi Arabia
- 8.1 Saudi Arabia Heart Failure Drug Market (2014-2019)
- 8.2 Saudi Arabia Heart Failure Drug Market Size by Type
- 8.3 Saudi Arabia Heart Failure Drug Market Size by Ejection Fraction Function
- 8.4 Heart Failure Drug Key Players in Saudi Arabia
- 9 UAE
- 9.1 UAE Heart Failure Drug Market (2014-2019)
- 9.2 UAE Heart Failure Drug Market Size by Type
- 9.3 UAE Heart Failure Drug Market Size by Ejection Fraction Function
- 9.2 Heart Failure Drug Key Players in UAE
- 10 Analysis of Heart Failure Drugs Industry Key Manufacturers
- 10.1 Novartis
- 10.1.1 Company Profile
- 10.1.2 Product Information
- 10.1.3 Revenue and Gross Margin
- 10.2 Pfizer
- 10.2.1 Company Profile
- 10.2.2 Product Information
- 10.2.3 Revenue and Gross Margin
- 10.3 AstraZeneca
- 10.3.1 Company Profile
- 10.3.2 Product Information
- 10.3.3 Revenue and Gross Margin
- 10.4 Hikma
- 10.4.1 Company Profile
- 10.4.2 Product Information
- 10.4.3 Revenue and Gross Margin
- 10.5 Teva
- 10.5.1 Company Profile
- 10.5.2 Product Information
- 10.5.3 Revenue and Gross Margin
- 10.6 Cipla
- 10.6.1 Company Profile
- 10.6.2 Product Information
- 10.6.3 Revenue and Gross Margin
- 10.7 Merck & Co
- 10.7.1 Company Profile
- 10.7.2 Product Information
- 10.7.3 Revenue and Gross Margin
- 10.8 Amgen
- 10.8.1 Company Profile
- 10.8.2 Product Information
- 10.8.3 Revenue and Gross Margin
- 10.9 Roche
- 10.9.1 Company Profile
- 10.9.2 Product Information
- 10.9.3 Revenue and Gross Margin
- 10.10 Sun Pharma
- 10.10.1 Company Profile
- 10.10.2 Product Information
- 10.10.3 Revenue and Gross Margin
- 10.11 Mylan
- 10.11.1 Company Profile
- 10.11.2 Product Information
- 10.11.3 Revenue and Gross Margin
- 11 Market Forecast 2019-2025
- 11.1 Market Size Forecast by Country
- 11.2 Turkey
- 11.3 Egypt
- 11.4 South Africa
- 11.5 Saudi Arabia
- 11.6 UAE
- 11.7 Forxiga and SGLT2 Future Penetration Analysis
- 11.7.1 Forxiga and SGLT2 Introduction
- 11.7.2 Forxiga and SGLT2 for Heart Failure Market Share Forecast 2022-2025
- 12 Analyst's Viewpoints/Conclusions
- 13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.2 Disclaimer
- 13.3 Author Details
- List of Tables and Figures
- Table Heart Failure Drug Key Market Segments
- Table Key Players Heart Failure Drug Covered in This Report
- Table Middle East Africa and Turkey Heart Failure Drug Market Size Growth Rate by Type (2019-2025) (M USD)
- Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Type in 2018
- Figure Angiotensin-Converting Enzyme (ACE) Inhibitors Features
- Table of Key Players of Angiotensin-Converting Enzyme (ACE) Inhibitors
- Figure Angiotensin II Receptor Blockers Features
- Table of Key Players of Angiotensin II Receptor Blockers
- Figure Angiotensin-Receptor Neprilysin Inhibitors (ARNIs) Features
- Table of Key Players of Angiotensin-Receptor Neprilysin Inhibitors (ARNIs)
- Figure Aldosterone Antagonists Features
- Table of Key Players of Aldosterone Antagonists
- Figure Beta Blockers Features
- Table of Key Players of Beta Blockers
- Figure Diuretics Features
- Table of Key Players of Diuretics
- Table Middle East Africa and Turkey Heart Failure Drug Market Size Growth by Ejection Fraction Function (2019-2025) (M USD)
- Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Ejection Fraction Function in 2018
- Figure Reduced Ejection Fraction Case Studies
- Figure Preserved Ejection Fraction Case Studies
- Figure Heart Failure Drug Report Years Considered
- Figure Middle East Africa and Turkey Heart Failure Drug Market Size and Growth Rate 2014-2025 (M USD)
- Table Middle East Africa and Turkey Heart Failure Drug Market Size by Country 2014-2025 (M USD)
- Table Middle East Africa and Turkey Heart Failure Drug Market Size by Country 2014-2019 (M USD)
- Table Middle East Africa and Turkey Heart Failure Drug Market Share by Country 2014-2019
- Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Country 2014-2019
- Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Country 2018
- Table Market Top Trends
- Table Market Drivers
- Table Market Opportunities
- Table Middle East Africa and Turkey Heart Failure Drug Revenue by Manufacturers (2018-2019) (M USD)
- Table Middle East Africa and Turkey Heart Failure Drug Market Share by Manufacturers (2018-2019)
- Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Manufacturers in 2018
- Table Middle East Africa and Turkey Heart Failure Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table Key Players Head office and Area Served
- Table Key Players Heart Failure Drug Product/Solution/Service
- Table Establishment Year of Key Heart Failure Drugs Manufacturers
- Table Mergers & Acquisitions, Expansion Plans
- Table Heart Failure Drug Sales Price by Products 2018
- Table Middle East Africa and Turkey Heart Failure Drug Market Size by Type (2014-2019) (M USD)
- Table Middle East Africa and Turkey Heart Failure Drug Market Size Share by Type (2014-2019)
- Figure Middle East Africa and Turkey Heart Failure Drug Market Share by Type (2014-2019)
- Table Middle East Africa and Turkey Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
- Table Middle East Africa and Turkey Heart Failure Drug Market Size Share by Ejection Fraction Function (2014-2019)
- Figure Middle East Africa and Turkey Heart Failure Drug Market Size Market Share by Ejection Fraction Function (2014-2019)
- Figure Middle East Africa and Turkey Heart Failure Drug Revenue Market Share by Ejection Fraction Function in 2018
- Figure Turkey Heart Failure Drug Market Size 2014-2019 (M USD)
- Table Turkey Heart Failure Drug Market Size by Type (2014-2019) (M USD)
- Table Turkey Heart Failure Drug Market Share by Type (2014-2019)
- Table Turkey Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
- Table Turkey Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
- Table Heart Failure Drug Key Players in Turkey
- Figure Egypt Heart Failure Drug Market Size 2014-2019 (M USD)
- Table Egypt Heart Failure Drug Market Size by Type (2014-2019) (M USD)
- Table Egypt Heart Failure Drug Market Share by Type (2014-2019)
- Table Egypt Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
- Table Egypt Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
- Table Heart Failure Drug Key Players in Egypt
- Figure South Africa Heart Failure Drug Market Size 2014-2019 (M USD)
- Table South Africa Heart Failure Drug Market Size by Type (2014-2019) (M USD)
- Table South Africa Heart Failure Drug Market Share by Type (2014-2019)
- Table South Africa Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
- Table South Africa Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
- Table Heart Failure Drug Key Players in South Africa
- Figure Saudi Arabia Heart Failure Drug Market Size 2014-2019 (M USD)
- Table Saudi Arabia Heart Failure Drug Market Size by Type (2014-2019) (M USD)
- Table Saudi Arabia Heart Failure Drug Market Share by Type (2014-2019)
- Table Saudi Arabia Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
- Table Saudi Arabia Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
- Table Heart Failure Drug Key Players in Saudi Arabia
- Figure UAE Heart Failure Drug Market Size 2014-2019 (M USD)
- Table UAE Heart Failure Drug Market Size by Type (2014-2019) (M USD)
- Table UAE Heart Failure Drug Market Share by Type (2014-2019)
- Table UAE Heart Failure Drug Market Size by Ejection Fraction Function (2014-2019) (M USD)
- Table UAE Heart Failure Drug Market Share by Ejection Fraction Function (2014-2019)
- Table Heart Failure Drug Key Players in UAE
- Table Novartis Company Profile
- Figure Heart Failure Drugs Product Picture of Novartis
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Novartis 2018-2019
- Table Pfizer Company Profile
- Figure Heart Failure Drugs Product Picture of Pfizer
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Pfizer 2018-2019
- Table AstraZeneca Company Profile
- Figure Heart Failure Drugs Product Picture of AstraZeneca
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of AstraZeneca 2018-2019
- Table Hikma Company Profile
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Hikma 2018-2019
- Table Teva Company Profile
- Figure Heart Failure Drugs Product Picture of Teva
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Teva 2018-2019
- Table Cipla Company Profile
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Cipla 2018-2019
- Table Merck & Co Company Profile
- Figure Heart Failure Drugs Product Picture of Merck & Co
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Merck & Co 2018-2019
- Table Amgen Company Profile
- Figure Heart Failure Drugs Product Picture of Amgen
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Amgen 2018-2019
- Table Roche Company Profile
- Figure Heart Failure Drugs Product Picture of Roche
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Roche 2018-2019
- Table Sun Pharma Company Profile
- Figure Heart Failure Drugs Product Picture of Sun Pharma
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Sun Pharma 2018-2019
- Table Mylan Company Profile
- Figure Heart Failure Drugs Product Picture of Mylan
- Table Heart Failure Drugs Revenue (M USD) and Gross Margin of Mylan 2018-2019
- Table Middle East Africa and Turkey Heart Failure Drug Market Size by Country (M USD) 2019-2025
- Figure Middle East Africa and Turkey Heart Failure Drug Market Size Share by Country (2019-2025)
- Figure Middle East Africa and Turkey Heart Failure Drug Market Size Share by Country in 2025
- Figure Turkey Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
- Figure Egypt Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
- Figure South Africa Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
- Figure Saudi Arabia Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
- Figure UAE Heart Failure Drug Market Size Forecast (2019-2025) (M USD)
- Table Global Forxiga and SGLT2 for Heart Failure Market Size Forecast 2022-2025 (M USD)
- Table Research Programs/Design for This Report
- Figure Bottom-up and Top-down Approaches for This Report
- Figure Data Triangulation
- Table Key Data Information from Secondary Sources
- Table Key Data Information from Primary Sources